{
    "2018-04-09": [
        [
            {
                "time": "2023-10-16",
                "original_text": "[强于大市评级]医药生物行业研究周报：医药配置价值仍在 细分龙头贯穿始终",
                "features": {
                    "keywords": [
                        "医药生物",
                        "配置价值",
                        "细分龙头"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "[增持评级]医药生物行业周报：仿制药进口替代、集中度提升趋势进一步明确",
                "features": {
                    "keywords": [
                        "医药生物",
                        "仿制药",
                        "进口替代",
                        "集中度提升"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "政策促仿制药进口替代加速 五股或闻风而动",
                "features": {
                    "keywords": [
                        "政策",
                        "仿制药",
                        "进口替代",
                        "五股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "金股预测早间版：8股有望开启估值修复",
                "features": {
                    "keywords": [
                        "金股",
                        "估值修复",
                        "8股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "医疗保健行业动态：仿制药改革提速 重点关药品相关板块",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "仿制药",
                        "改革提速",
                        "药品相关板块"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "政策促仿制药进口替代加速 机构看好8只龙头股",
                "features": {
                    "keywords": [
                        "政策",
                        "仿制药",
                        "进口替代",
                        "龙头股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}